IMRA

Imara Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

IMRA price

Imara

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IMRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IMRA

Valuation

P/E

0.00

Sector 1.03

Industry 14.35

P/BV

0.00

Sector 1.86

Industry 2.57

P/Revenue (PSR)

Sector 1.55

Industry 1.15

EV/EBITDA

27.06

Sector -28.64

Industry 26.90

EV/EBIT

27.06

Sector -28.82

Industry -31.74

P/EBITDA

Sector -32.29

Industry -9.26

P/EBIT

Sector -42.75

Industry 0.24

P/Total Assets

Sector 0.87

Industry 1.15

P/Net Current Assets

0.00

Sector -27.31

Industry -3.76

P/Working Capital

0.00

Sector -3.97

Industry 6.12

EPS

0.22

Sector -0.71

Industry 1.27

BVPS

12.88

Sector 4.32

Industry 15.27

Efficiency

Gross Margin

0.00%

Sector 49.17%

Industry 35.74%

EBITDA Margin

Sector -308.54%

Industry 5.37%

EBIT Margin

Sector -178.98%

Industry 3.08%

Operating Margin

0.00%

Sector -20.11%

Industry 2.20%

Net Profit Margins

0.00%

Sector -24.57%

Industry 3.24%

Asset Turnover

0.00

Sector 0.13

Industry 0.28

Profitability

ROE

1.74%

Sector -24.85%

Industry 8.71%

ROA

1.71%

Sector -24.72%

Industry 3.75%

ROIC

-724.58%

Sector -587.46%

Industry -2.36%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.62%

Debt

Current Ratio

48.98

Sector 1.92

Industry 1.48

Net Debt / EBITDA

27.06

Sector -5.39

Industry -10.12

Net Debt / EBIT

27.06

Sector -3.29

Industry -6.30

Net Debt / Equity

-0.98

Sector -0.46

Industry -0.04

Gross Debt / Equity

0.00

Sector -0.73

Industry 0.29

Equity/Assets

0.98

Sector 0.46

Industry 0.46

Liabilities/Assets

0.02

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals IMRA

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Imara ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$7.98

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IMRA Imara Inc.	$0.00	-100.00%	0.00%	0.00	0.00	1.74%	0.00%
ISRG Intuitive Surgical Inc.	$376.19	-16.34%	0.00%	41.36	7.14	17.26%	28.62%
ABT Abbott Laboratories	$101.91	-20.63%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$94.30	4.33%	3.17%	21.85	2.26	10.35%	14.02%
BSX Boston Scientific Corp.	$43.87	-57.29%	0.00%	17.35	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$90.08	-21.37%	0.00%	18.39	5.39	29.28%	22.69%
RMD ResMed Inc.	$233.73	-12.38%	1.11%	20.57	4.76	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.38	-20.24%	0.00%	34.83	24.62	70.67%	25.03%
COHR Coherent Inc.	$272.28	164.38%	0.00%	74.57	5.29	7.09%	11.19%
SYK Stryker Corp.	$280.58	-25.85%	1.29%	27.75	4.31	15.55%	14.43%
PHG Koninklijke Philips NV	$24.85	-8.43%	4.12%	18.14	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.90	0.44%	0.00%	11.23	1.38	12.32%	20.69%
DXCM DexCom Inc.	$86.27	13.18%	0.00%	33.80	12.89	38.14%	20.12%
BDX Becton Dickinson and Company	$186.01	2.56%	2.40%	50.94	1.97	3.86%	6.30%
EW Edwards Lifesciences Corp.	$85.66	10.43%	0.00%	48.54	4.54	9.36%	15.41%
ALGN Align Technology Inc.	$148.68	13.01%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$28.01	-23.33%	2.84%	19.16	4.45	23.22%	9.83%
IRMD iRadimed Corporation	$82.19	16.64%	1.54%	45.62	10.34	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$98.03	-3.64%	1.04%	21.92	1.40	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IMRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/25/2026	06/30/2026	0.12000000
Dividends	05/21/2026	05/27/2026	0.17100000
Dividends	04/23/2026	04/28/2026	0.14800000
Dividends	03/26/2026	03/31/2026	0.25000000
Dividends	02/26/2026	03/03/2026	0.30600000
Dividends	01/22/2026	01/27/2026	0.20800000
Dividends	12/25/2025	12/30/2025	1.41700000
Dividends	11/27/2025	12/02/2025	1.69400000
Dividends	10/23/2025	10/28/2025	3.01200000
Dividends	09/25/2025	09/30/2025	3.20000000
Dividends	08/21/2025	08/26/2025	2.90000000
Dividends	07/24/2025	07/29/2025	3.86500000
Dividends	06/26/2025	07/01/2025	1.89200000
Dividends	05/22/2025	05/28/2025	9.33000000

ABOUT Imara

Imara Inc.

Average Investor10 user rating

4.0 (14 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

27

Employees

Imara Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $90.13 million.

The company employs approximately 27 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Imara Inc. reported $- in revenue, generating net income of $1.57 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IMRA.

Market cap

Net worth

$90.13 million

$90,130,000.00

Assets

$91.96 million

$91,960,000.00

Total Shares Outstanding

7.00 million

7,000,000

Average Daily Trading Volume

$2.67 Thousand

$2,671.86

Sector

Health

Industry

Medical Supplies and Equipment

IMRA

IMRA revenue and profits

Financial Results IMRA

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.73 33,02% (12M)

P/E

-0.84

2.82%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$289.94 0,28% (12M)

P/E

10.69

2.22%

ROE

16.04%

P/BV

1.72

CNC - Centene

$67.36 106,37% (12M)

P/E

-6.30

0.00%

ROE

-22.56%

P/BV

1.42

HUM - Humana

$394.22 45,52% (12M)

P/E

37.65

0.87%

ROE

6.72%

P/BV

2.53

SNY - Sanofi

$42.70 --4,78% (12M)

P/E

3.98

4.16%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,141.58 53,54% (12M)

P/E

37.57

0.59%

ROE

78.84%

P/BV

29.62

HCA - HCA Healthcare

$424.84 6,07% (12M)

P/E

11.97

0.70%

ROE

-244.72%

P/BV

-29.30

NVS - Novartis

$138.72 14,68% (12M)

P/E

20.58

2.25%

ROE

30.39%

P/BV

6.25